GlaxoSmithKline Plc in Consumer Health (United Kingdom)

November 2015 | 2 pages | ID: G54F341268CEN
Euromonitor International Ltd

Abstracts

Within consumer health GlaxoSmithKline is expected to benefit from creating GSK Consumer Healthcare in 2015, with this bringing together Novartis and GlaxoSmithKline's brands. This new company is expected to focus on four key areas: Wellness, Oral Health, Nutrition and Skin Health. The company has identified seven power brands for strong development, including Otrivine, Panadol and Voltarol within UK consumer health. In the forecast period, the company will also focus on simplifying its...

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 GlaxoSmithKline Plc: Key Facts
  Summary 2 GlaxoSmithKline Plc: Operational Indicators
Competitive Positioning
  Summary 3 GlaxoSmithKline Plc: Competitive Position 2015